IGF1R and osteosarcoma: Furthermore, cisplatin-resistant osteosarcoma cells characterised by elevated basal activation of IGF-1R/AKT display hypersensitivity to nutlin-3a but reduced AKT-dependent autophagy flux, and inhibiting IGF-1R, AKT or autophagy flux improved the nutlin-3a response [215].